Insider Shareholders with Direct Ownership of Intellia Therapeutics, Inc. (NTLA)
This section provides a comprehensive overview of the insiders with direct ownership of Intellia Therapeutics, Inc. (NTLA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Intellia Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novartis Institutes For Bio Medical Research, Inc.
> 10% Shareholder |
5,652,903 | 1,523,000 | 4,129,903 $38.1 Million | 3 |
Dec 12, 2017
Reduced 26.94%
|
|
John M Leonard
President and CEO |
1,269,330 | 659,567 | 1,077,115 $9.94 Million | 45 |
Mar 01, 2025
Added 11.21%
|
|
Jose E Rivera
EVP, General Counsel |
263,203 | 137,677 | 162,388 $1.5 Million | 18 |
Apr 01, 2021
Reduced 0.08%
|
|
David Lebwohl
EVP, Chief Medical Officer |
159,064 | 31,025 | 130,866 $1.21 Million | 23 |
Mar 01, 2025
Added 24.82%
|
|
Edward J Dulac Iii
EVP, Chief Financial Officer |
113,524 | 0 | 113,524 $1.05 Million | 2 |
Mar 01, 2025
Added 29.37%
|
|
James Basta
EVP, General Counsel |
129,899 | 17,974 | 111,925 $1.03 Million | 10 |
Mar 04, 2025
Reduced 2.25%
|
|
Birgit C Schultes
EVP, Chief Scientific Officer |
37,600 | 0 | 105,215 $971,134 | 1 |
Mar 01, 2025
Added 26.33%
|
|
Eliana Clark
EVP, Chief Technical Officer |
109,430 | 21,663 | 95,369 $880,255 | 16 |
Mar 04, 2025
Reduced 0.71%
|
|
Laura Sepp Lorenzino
EVP, Chief Scientific Officer |
218,720 | 145,759 | 77,388 $714,291 | 17 |
Jan 03, 2025
Reduced 10.38%
|
|
Glenn Goddard
EVP, Chief Financial Officer |
131,500 | 62,287 | 69,213 $638,835 | 17 |
Mar 01, 2024
Added 29.26%
|
|
Derek Hicks
EVP, Chief Business Officer |
72,069 | 12,191 | 59,878 $552,673 | 6 |
Jan 03, 2025
Reduced 9.8%
|
|
Michael P Dube
VP, Chief Accounting Officer |
31,801 | 3,384 | 59,640 $550,477 | 4 |
Mar 01, 2025
Added 19.01%
|
| 47,453 | 0 | 57,453 $530,291 | 6 |
Jun 11, 2025
Added 12.22%
|
|
| 27,893 | 0 | 34,693 $320,216 | 4 |
Jun 11, 2025
Added 18.74%
|
|
| 32,408 | 0 | 31,883 $294,280 | 6 |
Jun 11, 2025
Added 20.06%
|
|
| 27,453 | 0 | 27,453 $253,391 | 5 |
Jun 11, 2025
Added 22.57%
|
|
| 30,130 | 2,927 | 27,203 $251,083 | 10 |
Jun 11, 2025
Added 22.73%
|
|
| 27,453 | 1,505 | 25,948 $239,500 | 6 |
Jun 11, 2025
Added 23.57%
|
|
| 23,409 | 0 | 23,409 $216,065 | 2 |
Jun 11, 2025
Added 25.47%
|
|
|
Andrew Schiermeier
EVP, Chief Operating Officer |
6,292 | 1,377 | 16,656 $153,734 | 3 |
Jan 05, 2021
Reduced 7.64%
|
|
Caroline Dorsa
Director |
14,791 | 7,500 | 12,701 $117,230 | 4 |
Jun 14, 2022
Added 29.04%
|
|
John F Crowley
Director |
24,216 | 12,500 | 11,716 $108,138 | 7 |
Jun 14, 2023
Added 27.41%
|
|
Jean Francois Formela
Director |
7,291 | 0 | 7,291 $67,295 | 2 |
Jun 14, 2022
Added 41.62%
|
|
Perry A Karsen
Director |
88,764 | 88,764 | 5,000 $46,150 | 2 |
Dec 17, 2020
Reduced 81.01%
|